Cited by 583Alzheimer's disease research and treatmentsNeurological Disease Mechanisms and TreatmentsAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.

Animal models of neurodegenerative diseases

Open access

Dawson, Ted M., Golde, Todd E., Lagier-Tourenne, Clotilde·2018·Nature Neuroscience

DOI 10.1038/s41593-018-0236-8PMC PMC6615039

Open this paper in CoChat — free account

Abstract

Animal models of adult-onset neurodegenerative diseases have enhanced the understanding of the molecular pathogenesis of Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Nevertheless, our understanding of these disorders and the development of mechanistically designed therapeutics can still benefit from more rigorous use of the models and from generation of animals that more faithfully recapitulate human disease. Here we review the current state of rodent models for Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. We discuss the limitations and utility of current models, issues regarding translatability, and future directions for developing animal models of these human disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41593-018-0236-8

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Intraneuronal APP, Not Free Aβ Peptides In 3xTg-AD Mice: Implications For Tau Versus Aβ Mediated Alzheimer Neurodegeneration
Winton, M. J., Lee, E. B., Sun, E., Wong, M. M., Leight, S., Zhang, B., Trojanowski, J., & Lee, V. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6637-10.2011 · Cited by 110
Retracted
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
α-Synuclein in Lewy bodies
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Prions
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 1×
“Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.”
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citation

Show all 151 references

Sorted by citations

Items 201–300 of 583

Nonrespiratory sites of influenza‐associated disease: mechanisms and experimental systems for continued study
Froggatt, H. M., & Heaton, N. S. (2022) · FEBS Journal · doi:10.1111/febs.16363 · Cited by 20
Oligonucleotide-based therapeutics for neurodegenerative disorders: Focus on antisense oligonucleotides
Mansour, H. M., & El-Khatib, A. S. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177529 · Cited by 20
Zebrafish as an Integrative Model for Central Nervous System Research: Current Advances and Translational Perspectives
Pansera, L., Mhalhel, K., Cavallaro, M., Aragona, M., Laurà, R., Levanti, M. B., Guerrera, M. C., Abbate, F., Germanà, A., & Montalbano, G. (2025) · Life · doi:10.3390/life15111751 · Cited by 19
Dictyostelium discoideum as a Model for Investigating Neurodegenerative Diseases
Haver, H. N., & Scaglione, K. M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.759532 · Cited by 20
Translational science: a survey of US biomedical researchers’ perspectives and practices
Walker, R. L., Saylor, K. W., Waltz, M., & Fisher, J. A. (2021) · Lab Animal · doi:10.1038/s41684-021-00890-0 · Cited by 20
Patient-derived three-dimensional cortical neurospheres to model Parkinson’s disease
Raja, W. K., Neves, E., Burke, C., Jiang, X. J., Xu, P., Rhodes, K. J., Khurana, V., Scannevin, R. H., & Chung, C. Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277532 · Cited by 19
Targeting G Protein-Coupled Receptors in the Treatment of Parkinson's Disease.
Jones-Tabah, J. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167927 · Cited by 18
Resveratrol prevents cognitive impairment and hippocampal inflammatory response induced by lipopolysaccharide in a mouse model of chronic neuroinflammation
Zeini, S., Davoodian, N., Kazemi, H., Brojeni, M. S., Ghani, E., Firouzjaei, M. A., & Atashabparvar, A. (2024) · Physiology & Behavior · doi:10.1016/j.physbeh.2024.114508 · Cited by 19
Early molecular events of autosomal‐dominant Alzheimer's disease in marmosets with PSEN1 mutations
Homanics, G. E., Park, J. E., Bailey, L. S., Schaeffer, D. J., Schaeffer, L. K. H., He, J., Li, S., Zhang, T., Haber, A., Spruce, C. A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13806 · Cited by 20
Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects
Collins, H. M., & Greenfield, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116222 · Cited by 21
Cyclodextrin-Containing Drug Delivery Systems and Their Applications in Neurodegenerative Disorders
Xing, Y., Meng, B., & Chen, Q. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910834 · Cited by 19
CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases
Rahman, S., Datta, M., Kim, J., & Jan, A. T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.014 · Cited by 19
Advanced 3D biomaterials and bioprinting strategies for in vitro modeling of neurodegenerative diseases
Gopalakrishnan, M., Kannan, D., Elumalai, K., Karunakar, K. K., Jayaraj, S., Devaraji, M., & Jayaprakash, N. (2025) · Biomedical Technology · doi:10.1016/j.bmt.2025.100089 · Cited by 18
Insights into Human-Induced Pluripotent Stem Cell-Derived Astrocytes in Neurodegenerative Disorders
Kumar, M., Nguyen, T. P. N., Milanese, M., & Bonanno, G. (2022) · Biomolecules · doi:10.3390/biom12030344 · Cited by 20
Zn homeostasis in genetic models of Parkinson’s disease in Caenorhabditis elegans
Baesler, J., Kopp, J. F., Pohl, G., Aschner, M., Haase, H., Schwerdtle, T., & Bornhorst, J. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.05.005 · Cited by 18
Multiparametric Assays for Accelerating Early Drug Discovery
Herholt, A., Galinski, S., Geyer, P. E., Rossner, M. J., & Wehr, M. C. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.02.005 · Cited by 18
The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation
Struzyna, L. A., & Watt, M. L. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.120.000142 · Cited by 20
Principles of brain aging: Status and challenges of modeling human molecular changes in mice
Kluever, V., & Fornasiero, E. F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101465 · Cited by 18
Alzheimer’s Disease: Current Perspectives and Advances in Physiological Modeling
Boder, E. J., & Banerjee, I. A. (2021) · Bioengineering · doi:10.3390/bioengineering8120211 · Cited by 18
Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases
Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000025 · Cited by 18
Intrathecal amyloid‐beta oligomer administration increases tau phosphorylation in the medial temporal lobe in the African green monkey: A nonhuman primate model of Alzheimer's disease
Wakeman, D. R., Weed, M. R., Perez, S. E., Cline, E. N., Viola, K. L., Wilcox, K. C., Moddrelle, D. S., Nisbett, E. Z., Kurian, A., Bell, A., et al. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12800 · Cited by 18
Particulate matter 2.5 (PM 2.5 ) - associated cognitive impairment and morbidity in humans and animal models: a systematic review
Chauhan, R., Dande, S., Hood, D. B., Chirwa, S., Langston, M. A., Grady, S. K., Dojcsak, L., Tabatabai, M., Wilus, D. M., Valdez, R. B., et al. (2025) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2025.2450354 · Cited by 18
A review on the impacts of nanomaterials on neuromodulation and neurological dysfunction using a zebrafish animal model
Cho, H.-J., Lee, W. S., Jeong, J., & Lee, J.-S. (2022) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2022.109428 · Cited by 21
A systematic review of the impact of environmental enrichment in zebrafish
Gallas‐Lopes, M., Benvenutti, R., Donzelli, N. I. Z., & Marcon, M. (2023) · Lab Animal · doi:10.1038/s41684-023-01288-w · Cited by 19
Investigating gut alterations in Alzheimer’s disease: In-depth analysis with micro- and nano-3D X-ray phase contrast tomography
Palermo, F., Marrocco, N., Dacomo, L., Grisafi, E., Moresi, V., Sanna, A., Massimi, L., Musella, M., Maugeri, L., Bukreeva, I., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr8511 · Cited by 17
HIV-Associated Neurocognitive Disorder (HAND): Relative Risk Factors
Kompella, S., Al-Khateeb, T., Riaz, O. A., Orimaye, S. O., Sodeke, P. O., Awujoola, A. O., Ikekwere, J. C., & Goodkin, K. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_131 · Cited by 18
A three-dimensional dementia model reveals spontaneous cell cycle re-entry and a senescence-associated secretory phenotype
Porterfield, V. M., Khan, S. S., Foff, E. P., Köseoğlu, M. M., Blanco, I. K., Jayaraman, S., Lien, E. L., McConnell, M. J., Bloom, G. S., Lazo, J. S., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.02.011 · Cited by 18
Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s disease
Miller, S. J., Darji, R. Y., Walaieh, S., Lewis, J. A., & Logan, R. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1271941 · Cited by 16
6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in C. elegans at Low Concentrations
Li, H., Dong, K., Zhao, M., Li, R., Shi, C., Wang, C., Wei, Y., Li, J., Chen, L., Zhao, Y., et al. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c02319 · Cited by 16
Long-term organotypic brain slices cultured on collagen-based microcontact prints: A perspective for a brain-on-a-chip
Steiner, K., & Humpel, C. (2023) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2023.109979 · Cited by 16
Enhanced innate responses in microglia derived from retinoblastoma patient‐specific iPSCs
Xu, J. M., Yu, S., Sun, S., Li, Y., Zhang, X., Jin, K., & Jin, Z. (2024) · Glia · doi:10.1002/glia.24507 · Cited by 16
Enhanced autophagic retrograde axonal transport by dynein intermediate chain upregulation improves Aβ clearance and cognitive function in APP/PS1 double transgenic mice
Zhou, F., Xiong, X., Li, S., Liang, J., Zhang, X., Tian, M., Li, X., Gao, M., Tang, L. P., & Li, Y. (2020) · Aging · doi:10.18632/aging.103382 · Cited by 16
An Experimental Model of Neurodegenerative Disease Based on Porcine Hemagglutinating Encephalomyelitis Virus–Related Lysosomal Abnormalities
Lan, Y., Li, Z., Wang, Z., Wang, X., Wang, G., Zhang, J., Hu, S., Zhao, K., Xu, B., Gao, F., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02105-y · Cited by 16
Detecting and Quantifying Ataxia-Related Motor Impairments in Rodents Using Markerless Motion Tracking With Deep Neural Networks
Lang, J., Haas, E., Hübener‐Schmid, J., Anderson, C. J., Pulst, S. M., Giese, M. A., & Ilg, W. (2020) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc44109.2020.9176701 · Cited by 16
Ghrelin as a treatment for amyotrophic lateral sclerosis
Ngo, S. T., Wang, H., Henderson, R. D., Bowers, C. Y., & Steyn, F. J. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12938 · Cited by 16
Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development
Lin, X., Tang, J., & Lou, Y. (2021) · Pharmaceuticals · doi:10.3390/ph14060525 · Cited by 16
Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges
Irrechukwu, O. (2023) · ALTEX · doi:10.14573/altex.2204071 · Cited by 18
On the reactive states of astrocytes in prion diseases
Baskakov, I. V. (2021) · Prion · doi:10.1080/19336896.2021.1930852 · Cited by 19
Research models to study lewy body dementia
Boschen, S. L., Mukerjee, A. A., Faroqi, A. H., Rabichow, B. E., & Fryer, J. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00837-w · Cited by 16
Quantitative Three-Dimensional Reconstructions of Excitatory Synaptic Boutons in the “Barrel Field” of the Adult “Reeler” Mouse Somatosensory Neocortex: A Comparative Fine-Scale Electron Microscopic Analysis with the Wild Type Mouse
Prume, M., Rollenhagen, A., Yakoubi, R., Sätzler, K., & Lübke, J. H. R. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz304 · Cited by 16
Sensor‐integrated brain‐on‐a‐chip platforms: Improving the predictive validity in neurodegenerative research
Spitz, S., Schobesberger, S., Brandauer, K., & Ertl, P. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10604 · Cited by 17
Rats Lacking the Dopamine Transporter Display Inflexibility in Innate and Learned Behavior
Belskaya, A. D., Kurzina, N. P., Savchenko, A. A., Sukhanov, I., Gromova, A. A., Gainetdinov, R. R., & Volnova, A. B. (2024) · Biomedicines · doi:10.3390/biomedicines12061270 · Cited by 15
Tackling neurodegeneration in vitro with omics: a path towards new targets and drugs
Carraro, C., Montgomery, J. V., Klimmt, J., Paquet, D., Schultze, J. L., & Beyer, M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1414886 · Cited by 16
Yeast models of neurodegenerative diseases
Tuite, M. F. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.07.001 · Cited by 15
Evaluation of animal model congruence to human depression based on large-scale gene expression patterns of the CNS
Gammie, S. C. (2022) · Scientific Reports · doi:10.1038/s41598-021-04020-1 · Cited by 16
Neurophysiological alterations in mice and humans carrying mutations in APP and PSEN1 genes
van Heusden, F. C., van Nifterick, A. M., Souza, B. C., França, A. S. C., Nauta, I. M., Stam, C. J., Scheltens, P., Smit, A. B., Gouw, A. A., & van Kesteren, R. E. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01287-6 · Cited by 16
Computational Analysis Indicates That PARP1 Acts as a Histone Deacetylases Interactor Sharing Common Lysine Residues for Acetylation, Ubiquitination, and SUMOylation in Alzheimer’s and Parkinson’s Disease
Gupta, R. V., & Kumar, P. (2021) · ACS Omega · doi:10.1021/acsomega.0c06168 · Cited by 15
Zebrafish Models of Autosomal Dominant Ataxias
Quelle‐Regaldie, A., Sobrido‐Cameán, D., Barreiro‐Iglesias, A., Sobrido, M. J., & Sanchez, L. E. (2021) · Cells · doi:10.3390/cells10020421 · Cited by 15
Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases – ERRATUM
Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000104 · Cited by 15
Animal models of trigeminal neuralgia: A commentary
Fried, K., & Hansson, P. T. (2020) · Molecular Pain · doi:10.1177/1744806920980538 · Cited by 15
Brain Organoids to Evaluate Cellular Therapies
García-Delgado, A. B., Campos‐Cuerva, R., Rosell‐Valle, C., Martín-López, M., Casado, C., Ferrari, D., Márquez-Rivas, J., Sánchez‐Pernaute, R., & Fernández‐Muñoz, B. (2022) · Animals · doi:10.3390/ani12223150 · Cited by 14
Microglial Expression of the Wnt Signaling ModulatorDKK2Differs between Human Alzheimer’s Disease Brains and Mouse Neurodegeneration Models
Aghaizu, N. D., Jolly, S., Samra, S. K., Kalmár, B., Craessaerts, K., Greensmith, L., Salinas, P. C., Strooper, B. D., & Whiting, P. J. (2023) · eNeuro · doi:10.1523/eneuro.0306-22.2022 · Cited by 14
Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
Bathe, T., Hery, G. P., Villareal, J. A. B., Phillips, J. L., Cohen, E. M., Sharma, R. V., Tsering, W., & Prokop, S. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01770-7 · Cited by 15
Status and future directions of clinical trials in Parkinson's disease
Söderbom, G. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.02.009 · Cited by 14
A Data-Driven Biophysical Computational Model of Parkinson’s Disease Based on Marmoset Monkeys
Ranieri, C. M., Pimentel, J. M., Romano, M. R., Elias, L. A., Romero, R. A. F., Lones, M. A., de Araújo, M. F. P., Vargas, P. A., & Moioli, R. C. (2021) · IEEE Access · doi:10.1109/access.2021.3108682 · Cited by 14
Clustered regularly interspaced short palindromic repeats as an advanced treatment for Parkinson's disease
Mehmood, A., Ali, W., Din, Z. U., Song, S., Sohail, M., Shah, W., Guo, J., Guo, R., Ilahi, I., Shah, S., et al. (2021) · Brain and Behavior · doi:10.1002/brb3.2280 · Cited by 14
Early Repetitive Transcranial Magnetic Stimulation Exerts Neuroprotective Effects and Improves Motor Functions in Hemiparkinsonian Rats
Hsieh, T.-H., He, X., Liu, H.-H., Chen, J. J., Peng, C., Liu, H., Rotenberg, A., Chen, K., Chang, M., Chiang, Y. H., et al. (2021) · Neural Plasticity · doi:10.1155/2021/1763533 · Cited by 14
Towards Zebrafish Models of CNS Channelopathies
Kolesnikova, T. O., Demin, K. A., Costa, F. V., Zabegalov, K. N., de Abreu, M. S., Gerasimova, E., & Kalueff, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213979 · Cited by 14
Human-induced pluripotent stem cell-derived microglia integrate into mouse retina and recapitulate features of endogenous microglia
Ma, W., Zhao, L., Xu, B., Fariss, R. N., Redmond, T. M., Zou, J., Wong, W. T., & Li, W. (2023) · eLife · doi:10.7554/elife.90695.3 · Cited by 14
Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration
Prakash, N. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1071731 · Cited by 15
Advancing precision medicine therapeutics for Parkinson’s utilizing a shared quantitative systems pharmacology model and framework
Denaro, C. A., Stephenson, D. T., Müller, M. L. T. M., Piccoli, B., & Azer, K. (2024) · Frontiers in Systems Biology · doi:10.3389/fsysb.2024.1351555 · Cited by 13
Experimental Models to Study Immune Dysfunction in the Pathogenesis of Parkinson’s Disease
Šaponjić, J., Mejı́as, R., Nikolovski, N., Dragić, M., Canak, A., Papoutsopoulou, S., Özdemir, Y., Fladmark, K. E., Ntavaroukas, P., Muluk, N. B., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084330 · Cited by 13
Dopamine and central dopaminergic circuitry in neurodegenerative diseases: Roles and mechanisms of action of natural phytochemicals
Ang, J.-J., Low, B., & Wong, P. (2024) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2024.100050 · Cited by 13
The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases
Klonarakis, M., Vos, M. D., Woo, E. K., Ralph, L. T., Thacker, J. S., & Gil‐Mohapel, J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104541 · Cited by 14
Current approaches to characterize micro- and macroscale circuit mechanisms of Parkinson’s disease in rodent models
Peng, Y., Schöneberg, N., Esposito, M. S., Geiger, J. R. P., Sharott, A., & Tovote, P. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114008 · Cited by 14
Bioluminescence Imaging with Functional Amyloid Reservoirs in Alzheimer’s Disease Models
Yang, J., Ding, W., Zhu, B., Zhen, S. Y., Kuang, S., Yang, J., Zhang, C. M., Wang, P., Yang, F., Yang, L., et al. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c02358 · Cited by 13
M1 Muscarinic Receptor Activation Rescues β-Amyloid-Induced Cognitive Impairment through AMPA Receptor GluA1 Subunit
Zhao, L., Chen, M.-W., Qian, Y., Yang, Q., Ge, Y., Chen, H., & Qiu, Y. L. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.007 · Cited by 13
Introduction for Stem Cell–Based Therapy for Neurodegenerative Diseases
Han, F., & Lu, P. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-4370-8_1 · Cited by 13
Diffusion tensor imaging‐based studies at the group‐level applied to animal models of neurodegenerative diseases
Müller, H.-P., Roselli, F., Rasche, V., & Kassubek, J. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00734 · Cited by 12
Organotypic cultures as aging associated disease models
Sanchez, M. M., Bagdasarian, I. A., Darch, W., & Morgan, J. T. (2022) · Aging · doi:10.18632/aging.204361 · Cited by 12
Progress in precision drug delivery systems for neurodegenerative diseases with muscle atrophy
Zhang, G., Hu, F., Zhang, Y., Li, D., Deng, Y., Yang, M., Huang, T., Deng, X., Li, Y., Fu, C., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111027 · Cited by 16
Hallmark Molecular and Pathological Features of POLG Disease are Recapitulated in Cerebral Organoids
Chen, A., Yangzom, T., Hong, Y., Lundberg, B. C., Sullivan, G. J., Tzoulis, C., Bindoff, L. A., & Liang, K. X. (2024) · Advanced Science · doi:10.1002/advs.202307136 · Cited by 12
Engineering blood–brain barrier microphysiological systems to model Alzheimer's disease monocyte penetration and infiltration
Gu, L., Mao, X., Tian, C., Yang, Y., Yang, K., Canfield, S. G., Zhu, D., Gu, M., & Guo, F. (2025) · Biomaterials Science · doi:10.1039/d5bm00204d · Cited by 15
Systematic comparison of basic animal models of cerebral hypoperfusion
Chrishtop, V. V., Nikonorova, V. G., Gutsalova, A., Rumyantseva, T. А., Dukhinova, M., & Salmina, A. B. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101715 · Cited by 12
Animal models for studies of alcohol effects on the trajectory of age-related cognitive decline
Foster, T. C. (2022) · Alcohol · doi:10.1016/j.alcohol.2022.04.005 · Cited by 12
PBPK model for antibody disposition in mouse brain: validation using large-pore microdialysis data
Wu, S., Prieult, F. L., Phipps, C. J., Mezler, M., & Shah, D. K. (2022) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-022-09823-x · Cited by 13
Drosophila as a Model System for the Identification of Pharmacological Therapies in Neurodegenerative Diseases
Solana‐Manrique, C., Moltó, M. D., Calap-Quintana, P., Sanz, F., Llorens, J. V., & Paricio, N. (2019) · Springer eBooks · doi:10.1007/978-981-13-2218-1_15 · Cited by 12
Pathology in Parkinson’s Disease
Halliday, G. M., & Fu, Y. (2025) · Cambridge University Press eBooks · doi:10.1017/9781108989855.018 · Cited by 12
Brain structure and working memory adaptations associated with maturation and aging in mice
Clifford, K. P., Miles, A. E., Prévot, T. D., Misquitta, K. A., Ellegood, J., Lerch, J. P., Sibille, E. L., Nikolova, Y. S., & Banasr, M. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1195748 · Cited by 13
Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer’s disease
Gammie, S. C., Messing, A., Hill, M. A., Kelm‐Nelson, C. A., & Hagemann, T. L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0291995 · Cited by 11
Monitoring of Electrophysiological Functions in Brain‐on‐a‐Chip and Brain Organoids
Song, J., Jeong, H. E., Choi, A. H., & Kim, H. N. (2024) · Advanced NanoBiomed Research · doi:10.1002/anbr.202400052 · Cited by 11
Targeting the RUNX3–miR-186-3p–DAT–IGF1R axis as a therapeutic strategy in a Parkinson’s disease model
Huang, P., Wan, Z., & Qu, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05535-7 · Cited by 11
Leveraging microbiome-based interventions to improve the management of neurodegenerative diseases: evidence for effects along the microbiota-gut-brain axis
Auclair‐Ouellet, N., Kassem, O., Bronner, S., Oula, M.-L., & Binda, S. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1699884 · Cited by 12
Striatal Cholinergic Dysregulation after Neonatal Decrease in X‐Linked Dystonia Parkinsonism‐Related TAF1 Isoforms
Cirnaru, M., Creus‐Muncunill, J., Nelson, S., Lewis, T. B., Watson, J. L., Ellerby, L., Gonzalez‐Alegre, P., & Ehrlich, M. E. (2021) · Movement Disorders · doi:10.1002/mds.28750 · Cited by 11
Mammalian Models in Alzheimer’s Research: An Update
Sharma, H., Chang, K., Hulme, J., & An, S. S. A. (2023) · Cells · doi:10.3390/cells12202459 · Cited by 12
Zebrafish Models of Autosomal Recessive Ataxias
Quelle‐Regaldie, A., Sobrido‐Cameán, D., Barreiro‐Iglesias, A., Sobrido, M. J., & Sanchez, L. E. (2021) · Cells · doi:10.3390/cells10040836 · Cited by 11
Corrigendum: T Cell Responses to Neural Autoantigens Are Similar in Alzheimer's Disease Patients and Age-Matched Healthy Controls
Dhanwani, R., Pham, J. W., Premlal, A. L. R., Frazier, A., Kumar, A., Pero, M. E., Bartolini, F., Dutra, J. R., Marder, K. S., Peters, B., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.641809 · Cited by 11
Methodological and analytical considerations for intra-operative microdialysis
Riviere-Cazaux, C., Rajani, K. R., Rahman, M., Oh, J., Brown, D. A., White, J. F., Himes, B. T., Jusué-Torres, I., Rodriguez, M., Warrington, A. E., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00497-2 · Cited by 10
Disentangling causality in brain aging: The complex interplay between glial senescence, neuroinflammation, and neurodegeneration
Suk, K. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115737 · Cited by 11
RETRACTED: Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases
Türkez, H., Altay, Ö., Yıldırım, S., Li, X., Yang, H., Bayram, C., Bolat, İ., Öner, S., Tozlu, Ö. Ö., Arslan, M. E., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121325 · Cited by 10
Retracted
Gait Ignition Failure in JNPL3 Human Tau-mutant Mice
Jang, H., Ryu, J. H., Shin, K.-M., Seo, N., Kim, G. H., Huh, Y. H., Pae, A. N., & Lee, K. J. (2019) · Experimental Neurobiology · doi:10.5607/en.2019.28.3.404 · Cited by 10
Variant in NHLRC2 leads to increased hnRNP C2 in developing neurons and the hippocampus of a mouse model of FINCA disease
Hiltunen, A. E., Kangas, S. M., Ohlmeier, S., Pietilä, I., Hiltunen, J., Tanila, H., McKerlie, C., Govindan, S., Tuominen, H. J., Kaarteenaho, R. L., et al. (2020) · Molecular Medicine · doi:10.1186/s10020-020-00245-4 · Cited by 10
Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
Calvo, B., Schembri-Wismayer, P., & Alonso, M. B. D. (2025) · Cells · doi:10.3390/cells14050347 · Cited by 9
Towards a Conceptual Framework to Better Understand the Advantages and Limitations of Model Organisms
Kunze, M., & Malfatti, F. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70071 · Cited by 9
An update on mammalian and non-mammalian animal models for biomarker development in neurodegenerative disorders
Mishra, R., & Upadhyay, A. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05668-y · Cited by 11
Advancement in modeling of Alzheimer’s disease: a comprehensive review of preclinical screening platforms
Adak, S., Singh, S., Jain, R., Tiwari, A., Singh, B., Kumar, S., Dadhwal, A., Chakroborty, A., Sharma, A. K., Singh, R. P., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1646551 · Cited by 12
Cholesterol, Amyloid Beta, Fructose, and LPS Influence ROS and ATP Concentrations and the Phagocytic Capacity of HMC3 Human Microglia Cell Line
Herrera, O. M. M., Hong, B. V., Mendiola, U. R., Maezawa, I., Jin, L., Lebrilla, C. B., Harvey, D. J., & Zivkovic, A. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210396 · Cited by 9
Nuclear GAPDH in cortical microglia mediates cellular stress-induced cognitive inflexibility
Ramos, A., Ishizuka, K., Hayashida, A., Namkung, H., Hayes, L. N., Srivastava, R., Zhang, M., Kariya, T., Elkins, N., Palen, T., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02553-1 · Cited by 9
Modeling Brain Pathology of Niemann‐Pick Disease Type C Using Patient‐Derived Neurons
Burbulla, L. F., Donald, J. M. M., Valdez, C., Gao, F., Bigio, E. H., & Krainc, D. (2021) · Movement Disorders · doi:10.1002/mds.28463 · Cited by 9
Neurodegenerative brain models vs. cell replacement or restoration therapy: A review on promises and pitfalls
Kumar, D., & Hassan, M. I. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.11.040 · Cited by 9

Authors: Dawson, T. M., Golde, T. E., & Lagier-Tourenne, C.
Affiliations: Johns Hopkins University (US)
University of Florida (US)
Corresponding author: Dawson, Ted M.
Golde, Todd E.
ORCID: Dawson, Ted M.
Golde, Todd E.
Lagier-Tourenne, Clotilde
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2018-09-24
Volume: 21
Issue: 10
Pages: 1370-1379
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/s41593-018-0236-8
PMC: PMC6615039
OpenAlex: W2891411797
Cited by: 576
References: 151
Citations by year: 2026: 59 · 2025: 73 · 2024: 89 · 2023: 72 · 2022: 88 · 2021: 79 · 2020: 70 · 2019: 41 · 2018: 4
FWCI: 6.37
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (R01AG018454, U01AG046139, P50AG047266)
National Cancer Institute (P01CA166009)
National Institute of Neurological Disorders and Stroke (R21NS098006, R01NS087227, R01NS082205, P50NS038377)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: animal models, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, frontotemporal dementia, amyotrophic lateral sclerosis, rodent models, translatability, disease modeling
MeSH terms: Animals, Disease Models, Animal, Humans, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Animal models of neurodegenerative diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks